40th Annual JP Morgan Healthcare Conference
10-11 January 2022
Safe Harbor Statement
This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing.
Fresenius does not undertake any responsibility to update the forward-looking statements contained in this presentation.
40th Annual JP Morgan Healthcare Conference, 10-11 January 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability | 2 |
Company Overview 02 03 04
Agenda
02 | 03 | 04 | |
Business Update | Financials Q3/21 | Attachments | |
Q3/21 | & Outlook | ||
40th Annual JP Morgan Healthcare Conference, 10-11 January 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability | 3 |
Company Overview 02 03 04
A Global Leader in Health Care Products and Services
in sales (FY/2020)
€ 36.3 bn
Global presence in 100+
countries
Leading market
#1 positions
Long-term opportunities in growing, non-cyclicalmarkets
100 +
Employees
worldwide
(as of September 30,
2021) 314,000+
Strong financial performance and cash flow generation
40th Annual JP Morgan Healthcare Conference, 10-11 January 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability | 4 |
Company Overview 02 03 04
Investment Highlights
Diversified healthcare Group | Leading positions in | Resilient business model |
with four strong business | growing non-cyclical | based on megatrends |
segments | markets | healthcare and demographics |
Purpose-driven business | Strong financial | Reliable | |||
delivers sustainable | performance and cash | dividend growth | |||
contribution to society | flow generation | ||||
40th Annual JP Morgan Healthcare Conference, 10-11 January 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability | 5 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Fresenius SE & Co. KGaA published this content on 03 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 January 2022 16:38:07 UTC.